Yazar "Yilmaz, Z. S." seçeneğine göre listele
Listeleniyor 1 - 4 / 4
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe THE COST-EFFECTIVENESS OF RIVAROXABAN COMPARED TO ENOXAPARIN PLUS ADJUSTED-DOSE WARFARIN FOR THE TREATMENT OF DEEP VENOUS THROMBOSIS (DVT) IN TURKEY(Elsevier Science Inc, 2013) Parali, E.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.; Ongen, Z.; Deger, C.; Marmarali, B.; Ozel, M. O.; Sumer, F.; Tuna, E.; Yilmaz, Z. S.Öğe THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY(Elsevier Science Inc, 2013) Marmarali, B.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.; Ongen, Z.; Deger, C.; Ozel, M. O.; Parali, E.; Sumer, F.; Tuna, E.; Yilmaz, Z. S.Öğe THE COST-OF-DISEASE OF DEEP VENOUS THROMBOSIS AND ITS SHORT- AND LONG-TERM CLINICAL CONSEQUENCES IN TURKEY: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS(Elsevier Science Inc, 2013) Deger, C.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.; Ongen, Z.; Marmarali, B.; Ozel, M. O.; Parali, E.; Sumer, F.; Tuna, E.; Yilmaz, Z. S.Öğe THE COST-OF-DISEASE OF THROMBOEMBOLIC AND HEMORRHAGIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION AND ITS TREATMENT IN TURKEY: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS(Elsevier Science Inc, 2013) Deger, C.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.; Ongen, Z.; Marmarali, B.; Ozel, M. O.; Parali, E.; Sumer, F.; Tuna, E.; Yilmaz, Z. S.
